United Kingdom
I am a motivated and detail-oriented research scientist specializing in clinical biomedical research and computational drug development. With strong adaptability, I excel in high-pressure, time-sensitive environments, ensuring quality results and seamless collaboration at all team levels. Holding a BSc in Biomedical Sciences (2:1) from Queen Mary University of London and an MSc in Cancer and Clinical Oncology from Bart’s and the London School of Medicine and Dentistry, I have a robust background in cancer research and drug discovery. My research has included identifying novel cytotoxic compounds for pancreatic cancer and critically evaluating immunotherapy's limitations as part of my MSc dissertation. Currently, I am a PhD candidate in Computational Chemistry at the University of the West of Scotland, where my research leverages in silico techniques to study the therapeutic potential of defensins against antibiotic-resistant ESKAPE pathogens using molecular dynamics simulations. This project aligns with the field’s growing emphasis on computational approaches to accelerate drug discovery and combat resistant infections.
Executed and presented independent scientific research projects to inform strategic direction and support R&D advancements for Centivax's therapeutic initiatives. Conducted rigorous computational analyses and literature reviews to produce evidence-based insights, guiding decisionmaking in product development and market positioning. Delivered comprehensive reports on competitive landscapes, market trends, and relevant scientific breakthroughs, applying data interpretation skills and industry knowledge to optimize research impact. Collaborated closely with cross-functional teams to translate findings into actionable strategies, contributing to Centivax’s mission to advance innovative solutions in immunology and infectious disease research. Work is supported by the Bill and Melinda Gates Foundation, Naval Medical Research Centre, Walter Reed Army Institute of Research, USAMRIID, National Institutes of Health, ThermoFischer Scientific, Charles River Laboratories.
Supported clinical trial project teams by managing essential trial logistics and documentation to ensure seamless study operations and regulatory readiness. Oversaw clinical supply inventories, including case report forms (CRFs) and investigational products, coordinating the tracking and timely shipment of all trial materials. Assisted in the preparation, review, and distribution of essential documentation, including the Operating Manual, Investigator Site File, Pharmacy File, Investigator Brochure, and study Protocol. Maintained study-specific tracking databases to monitor investigational product allocations, CRF progress, patient enrollment, and site payments, ensuring regulatory compliance and accuracy. Updated the Essential Document Tracker and Trial Master File (TMF) to facilitate quick document retrieval in preparation for FDA and MHRA inspections, ensuring all documentation met regulatory standards. Acted as the primary office-based contact for study sites, fostering strong relationships with investigators and site staff, and promoting high ethical standards.
Performed essential administrative duties to ensure the efficient operation of a multicenter, multinational clinical trial investigating the effects of intracoronary reinfusion of bone marrow-derived mononuclear cells on allcause mortality in acute myocardial infarction. Responsibilities included organizing and maintaining the Trial Master File (TMF) to ensure compliance and accessibility of all essential documents. Processed serious adverse events (SAEs) within 24 hours of receipt, ensuring timely reporting and coordination. Demonstrated a thorough understanding of Good Clinical Practice (GCP) guidelines, as well as the regulatory requirements set forth by the MHRA and ethical review boards, facilitating trial initiation and closeout processes. Actively contributed to maintaining adherence to protocols, ensuring that all trial activities met regulatory and ethical standards.